{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:56:13Z","timestamp":1791197773116,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,5]],"date-time":"2027-10-05T00:00:00Z","timestamp":1822694400000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014247","name":"Immune Tolerance Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaci.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:51:29Z","timestamp":1784908289000},"page":"1018-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epitope-specific IgE profiles are predictive of desensitization and remission in the IMPACT trial"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-9092","authenticated-orcid":false,"given":"Julie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samane","family":"Khoshbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle F.","family":"Huffaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Plaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn H.","family":"Baloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh A.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.07.008_bib1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaci.2015.01.002","article-title":"Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment","volume":"135","author":"Peters","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib2","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/all.16111","article-title":"Longitudinal peanut and Ara h 2 specific-IgE, -IgG4, and -IgG4\/-IgE ratios are associated with the natural resolution of peanut allergy in childhood","volume":"79","author":"Parker","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.008_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaci.2022.04.008","article-title":"The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study","volume":"150","author":"Peters","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib4","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jaci.2024.10.042","article-title":"Kinetics of early peanut allergy development and resolution in the EAT, LEAP, and PAS cohorts","volume":"156","author":"Foong","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300145","article-title":"Oral immunotherapy for peanut allergy in children 1 to less than 4 years of age","volume":"2","author":"Du Toit","year":"2023","journal-title":"NEJM Evid"},{"issue":"10322","key":"10.1016\/j.jaci.2026.07.008_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.008_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1159\/000548282","article-title":"Efficacy and safety of oral immunotherapy for peanut allergy: a GRADE-assessed systematic review and meta-analysis of randomised controlled trials","volume":"187","author":"Khan","year":"2026","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12268","article-title":"Efficacy and safety of oral immunotherapy for peanut, cow\u2019s milk, and hen\u2019s egg allergy: a systematic review of randomized controlled trials","volume":"13","author":"Lodge","year":"2023","journal-title":"Clin Transl Allergy"},{"issue":"10207","key":"10.1016\/j.jaci.2026.07.008_bib10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.008_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/all.16451","article-title":"Allergen-specific IgE is a stronger predictor of remission following peanut oral immunotherapy than age in children aged 1-10 years","volume":"80","author":"Ashley","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.008_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaip.2023.12.028","article-title":"Interaction between baseline participant factors and treatment effects following peanut oral immunotherapy","volume":"12","author":"Lloyd","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.008_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.anai.2021.04.003","article-title":"Peanut oral immunotherapy in a pediatric allergy clinic: patient factors associated with clinical outcomes","volume":"127","author":"Guarnieri","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaip.2025.11.008","article-title":"Dosing reactions and missed doses affect peanut oral immunotherapy outcomes","volume":"14","author":"Olayiwola","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.008_bib16","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1111\/all.14905","article-title":"Accurate and reproducible diagnosis of peanut allergy using epitope mapping","volume":"76","author":"Su\u00e1rez-Fari\u00f1as","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.008_bib17","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/all.15477","article-title":"Predicting probability of tolerating discrete amounts of peanut protein in allergic children using epitope-specific IgE antibody profiling","volume":"77","author":"Suprun","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.008_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2024.10.017","article-title":"Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial","volume":"155","author":"Suprun","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaci.2021.01.030","article-title":"Evolution of epitope-specific IgE and IgG4 antibodies in children enrolled in the LEAP trial","volume":"148","author":"Suarez-Farinas","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/bioinformatics\/btaa1064","article-title":"bbeaR: an R package and framework for epitope-specific antibody profiling","volume":"37","author":"Suprun","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2026.07.008_bib21","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2026.07.008_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54868-7","article-title":"Novel bead-based epitope assay is a sensitive and reliable tool for profiling epitope-specific antibody repertoire in food allergy","volume":"9","author":"Suprun","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.07.008_bib23","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.jaip.2024.09.007","article-title":"A streamlined strategy for basophil activation testing in a multicenter phase III clinical trial","volume":"12","author":"Su\u00e1rez-Fari\u00f1as","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.07.008_bib24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2025.06.022","article-title":"Kinetics of epitope-specific IgE and IgG4 in early peanut allergy development and resolution","volume":"156","author":"Su\u00e1rez-Fari\u00f1as","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.008_bib25","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2024.02.017","article-title":"Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy","volume":"153","author":"Keswani","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:57:34Z","timestamp":1791194254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926005245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0091674926005245"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.008","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitope-specific IgE profiles are predictive of desensitization and remission in the IMPACT trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}